| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 11/20/2008 | US20080287388 Human G-Protein Coupled Receptor |
| 11/20/2008 | US20080287385 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 11/20/2008 | US20080287374 Breast cancer-resistant protein inhibitor |
| 11/20/2008 | US20080287364 Bitter Taste Receptors |
| 11/20/2008 | US20080287353 Peptides and proteins for early liver development and antibodies thereto |
| 11/20/2008 | US20080287351 Nfkb Transcriptional Activity Inhibitory Agent and Anti-Inflammatory Agent and a Steroid Action Enhancing Agent |
| 11/20/2008 | US20080286806 Ligand for G-protein coupled receptor GPR43 and uses thereof |
| 11/20/2008 | US20080286789 Genomic polymorphism for predicting therapeutic response |
| 11/20/2008 | US20080286389 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 11/20/2008 | US20080286375 capable of releasing a protein drug continuously over a long period of time without initial burst release; dissolving a protein drug in H2o to obtain a water phase; dissolving sucrose acetate isobutyrate and a biodegradable polymer in an organic solvent to obtain an oil phase, emulsifying |
| 11/20/2008 | US20080286368 administered sublingually in combination with a bio/mucoadhesion promoting compound (e.g. hydroxypropyl cellulose) in a manner giving rise to pharmacologically effective plasma levels of zolpidam, morphine, sufentanyl etc.within a short time after administration to treat pain, insomnia, diabetes etc |
| 11/20/2008 | US20080286365 Method For Producing Solid-Lipid Composite Drug Particles |
| 11/20/2008 | US20080286352 Liposome Compositions |
| 11/20/2008 | US20080286341 Oral drug delivery; Arginine, Aspargine, Glutamic acid, Glutamine buffer coating buffer; nicotine, cyclodextrin complex core; polyacrylate cation exchanger; lozenges, tablets; reduce the urge to smoke |
| 11/20/2008 | US20080286340 Oral drug delivery; Arginine, Aspargine, Glutamic acid, Glutamine buffer coating buffer; nicotine, cyclodextrin complex core; polyacrylate cation exchanger; lozenges, tablets; reduce the urge to smoke |
| 11/20/2008 | US20080286289 Use of B Cell Expansion Agents in Generating Antibodies |
| 11/20/2008 | US20080286288 Vascular endothelial growth factor 2 |
| 11/20/2008 | US20080286284 Compositions of PSMA antibodies |
| 11/20/2008 | US20080286280 Stable Lyophilized Pharmaceutical Preparations of Monoclonal or polyclonal antibodies |
| 11/20/2008 | US20080286269 Anti-alpha(v)beta(6) antibodies and uses thereof |
| 11/20/2008 | US20080286261 Methods of modulating hair growth |
| 11/20/2008 | US20080286241 Transplantation of Differentiated Immature Adipocytes and Biodegradable Scaffold for Tissue Augmentation |
| 11/20/2008 | US20080286224 Use of a Lotion Composition on an Absorbent Article for Reducing Adherence of Feces or Menses to the Skin |
| 11/20/2008 | CA2686394A1 Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient |
| 11/20/2008 | CA2685994A1 Single-chain circular rna and method of producing the same |
| 11/20/2008 | CA2683941A1 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same |
| 11/19/2008 | EP1992636A2 Process for correction of a disulfide misfold in Fc molecules |
| 11/19/2008 | EP1992634A1 Oligonucleotide n3'- p5' thiophosphoramidates: their synthesis and use |
| 11/19/2008 | EP1992633A1 VEGI, an inhibitor of angiogenesis and tumor growth |
| 11/19/2008 | EP1992618A1 Polycyclic cinnamide derivative |
| 11/19/2008 | EP1992361A1 Remedy or preventive for digestive ulcer |
| 11/19/2008 | EP1992360A1 Joint use of tgf-beta signal inhibitor and antitumor agent |
| 11/19/2008 | EP1992348A1 Pharmaceutical combination |
| 11/19/2008 | EP1992343A1 Composition comprising a cholesterol absorption inhibitor, an HMG-CoA reductase inhibitor and a stabilizing agent |
| 11/19/2008 | EP1991270A2 Compositions and methods for prevention and treatment of cachexia |
| 11/19/2008 | EP1532138B1 Inhibitors of tyrosine kinases |
| 11/19/2008 | EP1470107B1 Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists |
| 11/19/2008 | EP1453539B1 Immunotherapeutic methods and systems |
| 11/19/2008 | EP1428537B1 Stabilized preparations containing antibody |
| 11/19/2008 | EP1427326B1 Combination therapy for the treatment of cancer |
| 11/19/2008 | EP1417349B1 Novel molecular target for neurotoxicity |
| 11/19/2008 | EP1372650B1 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 11/19/2008 | EP1343529B1 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 11/19/2008 | EP1307226B1 Vitronectin receptor antagonist pharmaceuticals |
| 11/19/2008 | EP1268775B1 The high bone mass gene of 11q13.3 |
| 11/19/2008 | EP0888120B1 Immunogenic hla binding peptide and its uses to treat hiv infection |
| 11/19/2008 | CN101309932A Novel mucin glycoprotein and use thereof |
| 11/19/2008 | CN101309916A Process for production of cinnamamide derivative |
| 11/19/2008 | CN101309746A Method for production of single- and multi-layer microcapsules |
| 11/19/2008 | CN101309696A Harmful bacterium control agent containing bacillus thuringiensis |
| 11/19/2008 | CN101309695A A method for preparing pig placental extract to use as a feed additive and use thereof |
| 11/19/2008 | CN101307107A Protein tau |
| 11/19/2008 | CN101307052A Method for preparing pyrrole-N-heterocyclic ring derivates and medical application thereof |
| 11/19/2008 | CN101307049A Alkaloid compounds, method for preparing same and applications as enzyme inhibitors |
| 11/19/2008 | CN101307046A Tripeptidyl peptidase inhibitors |
| 11/19/2008 | CN101307017A Amino-methyl substituted tetracycline compounds |
| 11/19/2008 | CN101306185A Traditional Chinese medicine taken orally for treating damp-heat depression-steam type bromidrosis |
| 11/19/2008 | CN101305837A Cigarette with function of invigorating vital function and inducing resuscitation |
| 11/19/2008 | CN100434420C Compound inhibiting dipeptidyl peptidase iv |
| 11/19/2008 | CN100434092C Prescription containing sweet clover component and its formulation |
| 11/19/2008 | CN100434082C Application of diarsenic trioxide in ion-exchange protein |
| 11/18/2008 | US7453010 trans-N-{5-[((2S)-3-{[4-(1,1'-Biphenyl-4-yl)cyclohexyl]amino}-2-hydroxypropyl)oxy]-2-hydroxyphenyl}methanesulfonamide; beta 3 receptor agonists; antiinflammtory agent; irritable bowel syndrome; obesity, diabeties, glaucoma, dysmenorrheal, depression, urinary incontinence, lipolysis or cicatrizing |
| 11/18/2008 | US7453006 Inositol derivatives for increasing chloride secretion and inhibiting inflammation |
| 11/18/2008 | US7452995 Aryl aniline β2 adrenergic receptor agonists |
| 11/18/2008 | US7452977 Antibody to a kinase capable of site-specific phosphorylation of IκBα |
| 11/18/2008 | US7452908 Amide derivatives |
| 11/18/2008 | US7452907 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method |
| 11/18/2008 | US7452905 Phenylalanine derivatives |
| 11/18/2008 | US7452904 1-alkyl-1-azoniabicyclo' 2.2.2 octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 11/18/2008 | US7452900 Esters in position 20 of camptothecins |
| 11/18/2008 | US7452898 Use of 1-O-octadecylpropanediol-3-cidofovir to treat viral diseases such as HIV, influenza, herpes virus, cytomegalovirus, hepatitis virus, Epstein-Barr virus, varicella zoster virus, orthopox virus, ebola virus and papilloma virus |
| 11/18/2008 | US7452894 Purine derivatives as purinergic receptor antagonists |
| 11/18/2008 | US7452891 MCH antagonists and their use in the treatment of obesity |
| 11/18/2008 | US7452890 Substituted pyrazoles |
| 11/18/2008 | US7452888 Quinoline and aza indole compounds having pharmacological activity, for example, 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; use in the treatment of CNS and other disorders |
| 11/18/2008 | US7452886 E.g., 6-(6-Chloro-pyridin-3-yloxymethyl)-7-(2,2-dimethyl-propyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; in particular, cathepsin K inhibitors; osteoporosis; oral, autoimmune and respiratory diseases; osteoarthritis; antiarthritic and antitumor agents; muscular dystrophy; amytrophy; parasiticides |
| 11/18/2008 | US7452881 Such as N-[3-(2-diethylaminoethyl)-1H-indol-5-yl]-5-chloro-3-methylbenzo[b]thiophene-2-sulphonamide; serotonin receptors antagonist; anxiolytic, antidepressant, cognitive activator, senile dementia, psychosis, attention deficit/hyperactivity disorder |
| 11/18/2008 | US7452877 Irritable bowel disorders; controlling permeability of intestine tissue ; anticholinergic agent |
| 11/18/2008 | US7452874 Thrombopoietin mimetics |
| 11/18/2008 | US7452873 Inhibitors of GSK-3 and uses thereof |
| 11/18/2008 | US7452859 Having serine protease inhibitory activity |
| 11/18/2008 | US7452535 Methods of treatment using CTLA-4 antibodies |
| 11/18/2008 | US7452533 Antimicrobial polymer conjugate containing lysostaphin and polyethylene glycol |
| 11/18/2008 | CA2469369C Compositions containing both sedative and non-sedative antihistamines |
| 11/18/2008 | CA2455539C Pig growth enhancer and pig growth enhancing method |
| 11/18/2008 | CA2440222C Triazolopyridines as anti-inflammatory agents |
| 11/18/2008 | CA2423659C Antiviral composition and treatment method |
| 11/18/2008 | CA2422379C Pyrazole compounds useful as protein kinase inhibitors |
| 11/18/2008 | CA2413163C 3'-prodrugs of 2'-deoxy-.beta.-l-nucleosides |
| 11/18/2008 | CA2395481C Hormone receptor modulation |
| 11/18/2008 | CA2385986C New use of modafinil and the d/l enantiomers for enhancing sexual function in mammals |
| 11/18/2008 | CA2383630C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 11/18/2008 | CA2381219C Monomeric protein of the tgf-beta family |
| 11/18/2008 | CA2338721C New cofactors for methyltransferases |
| 11/18/2008 | CA2320822C Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 11/18/2008 | CA2318184C Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative as selective endothelin antagonists |
| 11/18/2008 | CA2301725C Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses |
| 11/18/2008 | CA2247115C Inhibition of selectin binding |
| 11/18/2008 | CA2245125C Use of one extract of at least one rosaceae plant |
| 11/18/2008 | CA2241941C Therapeutic agent containing .omega.-feline interferon for treating feline aids virus infections and feline atopic dermatitis |